-
08:30
-08:37
Serum proteomics identifies a functionally validated four-protein panel for endometrial cancer diagnosis
-
08:37
-08:44
Tertiary lymphoid structures improved survival outcomes in patients with endometrial cancer: a single team experience
-
08:44
-08:51
Multi-omic dissection of NSMP endometrial cancer links prognostic heterogeneity to routine-pathology risk stratification and Wnt-associated vulnerability
-
08:51
-08:58
Prognostic evaluation and risk stratification of the 2023 FIGO staging system for endometrial cancer incorporating molecular classification
-
08:58
-09:05
Prognostic significance of peritoneal cytology across molecular subtypes of endometrial cancer
-
09:05
-09:12
Three-gene methylation (CELF4, ZSCAN12, and BMP3) analysis outperforms cytology in detecting endometrial cancer: a prospective cohort study using endometrial brush samples
-
09:12
-09:19
Routine clinical and serological variables reveal reproducible phenotypic heterogeneity in early-stage NSMP endometrial cancer: a multicenter exploratory study
-
09:19
-09:26
Whole-slide digital quantification reveals primary–metastatic heterogeneity of folate receptor alpha expression in uterine serous carcinoma

